{"id":"https://openalex.org/W2590748746","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.173","title":"Effect of PEDF on the in vivo antitumor activities of low-dose chemotherapy in CRPC.","display_name":"Effect of PEDF on the in vivo antitumor activities of low-dose chemotherapy in CRPC.","publication_year":2013,"publication_date":"2013-02-20","ids":{"openalex":"https://openalex.org/W2590748746","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.173","mag":"2590748746"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.6_suppl.173","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.173","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.173","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066792434","display_name":"Thomas Nelius","orcid":"https://orcid.org/0000-0001-8858-5602","observed_orcids":["https://orcid.org/0000-0001-8858-5602"]},"institutions":[{"id":"https://openalex.org/I926076166","display_name":"Texas Tech University Health Sciences Center","ror":"https://ror.org/033ztpr93","country_code":"US","type":"education","lineage":["https://openalex.org/I926076166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Nelius","raw_affiliation_strings":["Texas Tech University Health Sciences Center, Lubbock, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Tech University Health Sciences Center, Lubbock, TX","institution_ids":["https://openalex.org/I926076166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052437060","display_name":"Everardo Cobos","orcid":"https://orcid.org/0000-0001-5799-0074","observed_orcids":["https://orcid.org/0000-0001-5799-0074"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Everardo Cobos","raw_affiliation_strings":["Southwest Cancer Treatment and Research Center, Lubbock, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southwest Cancer Treatment and Research Center, Lubbock, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Hirsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I926076166","display_name":"Texas Tech University Health Sciences Center","ror":"https://ror.org/033ztpr93","country_code":"US","type":"education","lineage":["https://openalex.org/I926076166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Hirsch","raw_affiliation_strings":["Texas Tech University Health Sciences Center, Lubbock, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Tech University Health Sciences Center, Lubbock, TX","institution_ids":["https://openalex.org/I926076166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002277031","display_name":"St\u00e9phanie Filleur","orcid":"https://orcid.org/0000-0002-3420-5536","observed_orcids":["https://orcid.org/0000-0002-3420-5536"]},"institutions":[{"id":"https://openalex.org/I926076166","display_name":"Texas Tech University Health Sciences Center","ror":"https://ror.org/033ztpr93","country_code":"US","type":"education","lineage":["https://openalex.org/I926076166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Filleur","raw_affiliation_strings":["Texas Tech University Health Sciences Center, Lubbock, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Tech University Health Sciences Center, Lubbock, TX","institution_ids":["https://openalex.org/I926076166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"6_suppl","first_page":"173","last_page":"173"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9010000228881836},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/low-dose-chemotherapy","display_name":"low-dose chemotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":1.0},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7099999785423279},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6029999852180481},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.9620000123977661},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6690000295639038},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4950000047683716},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.5929999947547913}],"concepts":[{"id":"https://openalex.org/C52237779","wikidata":"https://www.wikidata.org/wiki/Q18030441","display_name":"PEDF","level":3,"score":0.968859076499939},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6219784617424011},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.547159731388092},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5349705219268799},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.512423574924469},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48679324984550476},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.47414132952690125},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3291800618171692},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.32807034254074097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3037310242652893},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2611597776412964},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.254332572221756},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.6_suppl.173","doi":"https://doi.org/10.1200/jco.2013.31.6_suppl.173","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.6_suppl.173","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4240085689","https://openalex.org/W2560163808","https://openalex.org/W2319939324","https://openalex.org/W2071905242","https://openalex.org/W2333195195","https://openalex.org/W2071201073","https://openalex.org/W2080277895","https://openalex.org/W2589875561","https://openalex.org/W2481125971","https://openalex.org/W2601706262"],"abstract_inverted_index":{"173":[0],"Background:":[1],"The":[2],"development":[3,221],"of":[4,8,19,45,85,189,193,209,222,244,261,292,305,314,330],"metronomic/low":[5],"dose":[6,87,263,297,332],"administration":[7],"conventional":[9],"chemotherapeutic":[10],"drugs":[11],"has":[12],"shown":[13],"great":[14],"promise":[15],"in":[16,35,47,55,67,94,119,136,147,169,212],"the":[17,43,58,68,82,108,170,186,190,203,207,220,230,241,258,290,303,312,327],"treatment":[18,313],"castration-refractory":[20],"prostate":[21,36,192],"cancer":[22],"(CPRC).":[23],"Pigment":[24],"Epithelium-Derived":[25],"Factor":[26],"(PEDF)":[27],"is":[28,33],"a":[29,308,321],"natural":[30],"angio-inhibitor":[31],"which":[32],"down-regulated":[34],"cancer.":[37],"We":[38,75,197],"have":[39],"previously":[40],"demonstrated":[41,254],"that":[42,78,199,255],"over-expression":[44],"PEDF":[46,64,79,122,138,200,233,256,306,319],"human":[48],"CRPC":[49,71],"PC3":[50,97,224,274,284],"cells":[51,116,184,211],"decreased":[52],"tumor":[53],"growth":[54,131],"vivo.":[56,95],"In":[57,229],"present":[59],"study,":[60,232],"we":[61,253],"further":[62],"validated":[63],"anti-tumor":[65,139,328],"properties":[66],"highly":[69],"metastatic":[70],"LNCaP-derivative":[72],"CL1":[73,99,226,245],"cells.":[74],"also":[76,317],"hypothesized":[77],"may":[80],"enhance":[81,326],"cytotoxicity":[83,259],"effects":[84,140,260],"low":[86,262,296,331],"docetaxel":[88],"(DTX)":[89],"and":[90,98,133,205,214,218,225,275,285,287],"cyclophosphamide":[91],"(CTX)":[92],"chemotherapies":[93],"Methods:":[96],"cell":[100],"lines":[101],"were":[102,117,141,177],"genetically":[103],"modified":[104],"to":[105,325],"stably":[106],"express":[107],"fluorescent":[109],"DsRed":[110],"Express":[111],"protein":[112],"with":[113,150],"PEDF.":[114],"Resulting":[115],"characterized":[118],"vitro":[120],"for":[121,128,160,273,277,283,311],"expression":[123,201,234],"by":[124,130,179,216],"western":[125],"blot":[126],"and,":[127],"proliferation":[129,204],"curves":[132],"clone":[134],"formation":[135],"matrigel.":[137],"assessed":[142],"on":[143,265],"established":[144,266],"s.c.":[145,223,267],"xenografts":[146],"mice":[148,247,294],"treated":[149],"DTX":[151],"(5mg/kg":[152],"ip":[153,158],"every":[154,164],"4":[155],"days,":[156,162],"1mg/kg":[157,272],"daily":[159],"10":[161],"0.5mg/kg":[163],"other":[165],"day),":[166],"CTX":[167,280],"(10-20mg/kg":[168],"drinking":[171],"water)":[172],"or":[173,182],"placebo.":[174],"Survival":[175],"studies":[176],"performed":[178],"injecting":[180],"CL1-PEDF":[181],"-control":[183],"into":[185],"left":[187],"lobe":[188],"dorsal":[191],"anesthetized":[194],"mice.":[195],"Results:":[196],"showed":[198],"inhibits":[202],"induces":[206],"differentiation":[208],"CPRC":[210],"vitro,":[213],"decreases":[215],"85%":[217],"70%":[219],"tumors,":[227],"respectively.":[228],"survival":[231,243,291],"prolongs":[235,288],"significantly":[236,289],"(P=0.01;":[237],"95%":[238],"confidence":[239],"interval)":[240],"median":[242],"tumor-bearing":[246,293],"(53\u00b10.001":[248],"days":[249],"versus":[250],"57\u00b11).":[251],"Furthermore,":[252],"enhances":[257],"chemotherapy":[264],"tumors":[268],"(best":[269],"Doc":[270],"dose:":[271,281],"5mg/kg":[276],"CL1;":[278],"best":[279],"10mg/kg":[282],"CL1)":[286],"undergoing":[295],"chemotherapy.":[298],"Conclusions:":[299],"These":[300],"data":[301],"reinforce":[302],"significance":[304],"as":[307,320],"potent":[309],"target":[310],"CRPC.":[315],"It":[316],"emphasizes":[318],"promising":[322],"new":[323],"agent":[324],"efficacy":[329],"chemotherapies.":[333]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-03T00:00:00"}